In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Start-Up Previews, July-August 2014

Executive Summary

This Month's Profile Groups: Biopharma In Sweden, features profiles of Northern Light Pharmaceuticals, Sigrid Therapeutics, and Swecure; ENT Devices features profiles of Aerin Medical, ENTvantage Diagnostics, Fiagon, and Spirox. Plus these Start-Ups Across Health Care: Anagnostics Bioanalysis, Check-Cap, Edico Genome, G1 Therapeutics, HeadSense Medical, Innovent Biologics, Navitor Pharmaceuticals, Onciomed, and RevMedx.

You may also be interested in...

RevMedx Inc.

RevMedx Inc. received FDA de novo approval in April for battlefield use of XStat, which treats noncompressible bleeding from internal wounds. The injectable sponges of XStat expand upon contact with blood to fill the wound cavity, thus creating a temporary barrier and providing hemostatic pressure until hospital care can be rendered.

Anagnostics Bioanalysis GMBH

Rather than waiting up to one full week to confirm suspected cases of sepsis through a routine blood test that uses conventional microbiologyi, the hyborg cylindrical microarray platform from Austria’s Anagnostics Bioanalysis GMBH delivers results in a mere four hours.

Fiagon AG Medical Technologies

The FlexPointer from Fiagon AG Medical Technologies is a surgical navigation system that calculates the correct position of the instrument in patients’ sinuses. It can be used in any part of any sinus, without the need to exchange navigational instruments during a procedure.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts